HWM
Hohimer Wealth Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-59,194
| Closed | -$2.54M | – | 234 |
|
|
2024
Q1 | $2.54M | Sell |
59,194
-443
| -0.7% | -$19K | 0.59% | 64 |
|
|
2023
Q4 | $2.21M | Buy |
59,637
+66
| +0.1% | +$2.45K | 0.56% | 62 |
|
|
2023
Q3 | $2.16M | Sell |
59,571
-3,050
| -5% | -$111K | 0.62% | 56 |
|
|
2023
Q2 | $2.23M | Sell |
62,621
-2,373
| -4% | -$84.6K | 0.62% | 61 |
|
|
2023
Q1 | $2.31M | Buy |
64,994
+51,861
| +395% | +$1.85M | 0.67% | 58 |
|
|
2022
Q4 | $461K | Sell |
13,133
-38,534
| -75% | -$1.35M | 0.15% | 117 |
|
|
2022
Q3 | $1.52M | Sell |
51,667
-10,065
| -16% | -$296K | 0.49% | 73 |
|
|
2022
Q2 | $2.69M | Sell |
61,732
-9,030
| -13% | -$393K | 0.79% | 51 |
|
|
2022
Q1 | $3.08M | Buy |
70,762
+5,585
| +9% | +$243K | 0.61% | 65 |
|
|
2021
Q4 | $2.87M | Buy |
65,177
+246
| +0.4% | +$10.8K | 0.61% | 62 |
|
|
2021
Q3 | $2.48M | Buy |
64,931
+5,490
| +9% | +$210K | 0.52% | 74 |
|
|
2021
Q2 | $2.37M | Buy |
59,441
+6,005
| +11% | +$239K | 0.48% | 81 |
|
|
2021
Q1 | $1.91M | Buy |
53,436
+11,293
| +27% | +$403K | 0.46% | 77 |
|
|
2020
Q4 | $1.55M | Sell |
42,143
-2,687
| -6% | -$98.9K | 0.41% | 77 |
|
|
2020
Q3 | $1.62M | Sell |
44,830
-463
| -1% | -$16.8K | 0.46% | 73 |
|
|
2020
Q2 | $1.85M | Sell |
45,293
-1,708
| -4% | -$69.7K | 0.64% | 52 |
|
|
2020
Q1 | $2M | Buy |
47,001
+9,205
| +24% | +$392K | 0.85% | 37 |
|
|
2019
Q4 | $1.78M | Buy |
+37,796
| New | +$1.78M | 0.62% | 65 |
|